Federal Policy Shifts Could Open Door to Big Ag in Cannabis

A convergence of federal regulatory changes expected around 2026 could finally create conditions for major agricultural corporations to enter the cannabis market—a barrier that has kept players like Monsanto (now Bayer) on the sidelines for years.

The key changes center on how cannabis seeds are regulated and the ongoing rescheduling process. Under proposed rules, seeds would be classified by their THC potential rather than the plant's actual THC content at harvest. This shift, combined with potential rescheduling from Schedule I to Schedule III, would fundamentally alter the legal landscape for seed genetics and large-scale cultivation.

"The structural barriers that kept big agriculture out weren't just about federal illegality," explains industry analyst Sarah Chen of Green Market Report. "It was the patchwork of state regulations and the inability to patent or protect seed genetics under federal law."

Why Big Ag Stayed Out

Monsanto and similar agribusiness giants have historically avoided cannabis despite the crop's obvious commercial potential. The reasons were practical: Schedule I status meant no federal patent protection, state-by-state licensing created impossible compliance costs, and banking restrictions made normal business operations nearly impossible.

But the company's absence wasn't for lack of interest. Internal documents from the 1990s showed Monsanto researchers exploring cannabis genetics, only to shelve the work due to legal constraints. Other major seed companies faced the same calculation—the risk-reward ratio simply didn't work.

The current regulatory framework also made it difficult to develop and commercialize standardized seed varieties. Without federal recognition, genetic improvements couldn't be protected through traditional plant patents or Plant Variety Protection certificates.

The 2026 Window

Two specific policy changes could shift this equation. First, the DEA's ongoing rescheduling review, which could move cannabis to Schedule III by late 2025 or early 2026, would remove certain research restrictions and potentially open pathways for federal patent protection.

Second, proposed USDA rules on hemp seed classification—which may extend to cannabis seeds post-rescheduling—would regulate based on genetic THC potential rather than actual plant THC at harvest. This distinction matters enormously for seed companies, as it provides clear regulatory boundaries for developing and selling genetics.

The timeline isn't coincidental. Several state markets are also maturing their seed-to-sale tracking systems, creating more standardized data that large companies need for supply chain management.

Industry Concerns

Small-scale cultivators and craft cannabis advocates have long worried about corporate consolidation. The entry of major agricultural firms could accelerate a trend already visible in mature markets like Colorado and California, where small operators struggle against well-capitalized competitors.

"We've seen this movie before in organic food, craft beer, and other agricultural sectors," says Michael Torres, executive director of the Independent Cannabis Growers Association. "Once the big players come in with patented genetics and volume pricing, the craft producers get squeezed."

Some industry observers argue the ship has already sailed. Multi-state operators like Curaleaf and Trulieve already operate at scales comparable to mid-sized agricultural companies. What's different is the potential for true agricultural conglomerates with global supply chains and R&D budgets in the hundreds of millions.

What's Next

The DEA's rescheduling decision, currently under review at the White House Office of Management and Budget, is expected by mid-2025. USDA seed regulations would likely follow within 12-18 months of any rescheduling announcement.

Industry sources suggest several major agricultural companies have quietly assembled cannabis research teams in anticipation of regulatory changes. None have publicly announced cannabis programs, but patent filings and key hires suggest preparation is underway.

Whether 2026 actually becomes the inflection point depends on how quickly federal agencies move and whether state markets remain economically viable enough to attract major capital. But for the first time since legalization began, the structural barriers that kept big agriculture out are starting to crack.

This article is based on original reporting by hightimes.com.